| GlobeNewswire

Dova Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Dova Pharmaceuticals, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – DOVA

NEW YORK, Oct. 12, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) to Swedish Orphan Biovitrum AB (“Sobi”) is fair to Dova shareholders. On behalf of Dova shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

If you are a Dova shareholder and would like to discuss your legal rights and options, please visit Dova Merger or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Under the terms of the agreement, Dova shareholders will be offered an upfront payment for $27.50 per share in cash and one non-tradeable Contingent Value Right to an additional $1.50 per share in cash upon regulatory approval of DOPTELET.

The Dova merger investigation concerns whether Dova and its Board of Directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to: (1) obtain the best possible price for Dova shareholders; (2) determine whether Sobi is underpaying for Dova; and (3) disclose all material information necessary for Dova shareholders to adequately assess and value the merger consideration.

If you are a Dova shareholder and would like to discuss your legal rights and options, please visit  https://halpersadeh.com/actions/dova-pharmaceuticals-inc-sobi-stock-merger-swedish/# or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

Comments

FactsbySpencer-profile-image
Spencer Lasday @FactsbySpencer - 3 hours ago
Do the numbers. Beat the odds. Remain humble. 🚀 $DOVA https://t.co/hAc7D1feM8
stockjackpro-profile-image
Stock Trader Jack @stockjackpro - 7 hours ago
RT @stockjackpro: My Favorite Breakout Pattern for Penny Stocks ($PED) https://t.co/E1PT20HzI8 $DOVA $USAT $ENOB $AIRT $GTT $CAPR $DOVA $…
lblegend33-profile-image
BIO NEWMAN @lblegend33 - 7 hours ago
@juliaskripkaser Haha nope. $dova did the same thing and everyone said the exact same thing and that ended how I thought it would 😉
lblegend33-profile-image
BIO NEWMAN @lblegend33 - 7 hours ago
@juliaskripkaser You’re prob in the loud ones every thinks get bought or bs rumors. $amrn $bhvn $alxn etc etc etc.… https://t.co/r6lz36WPFM
ProTradersNews-profile-image
ProTradersNews @ProTradersNews - 7 hours ago
$PVTL $DOVA: Moore Kuehn, PLLC Encourages Milacron Holdings Corp. (MCRN …: https://t.co/cQ8KWenwNr
dailypoliticaln-profile-image
Daily Political @dailypoliticaln - 12 hours ago
Dova Pharmaceuticals $DOVA Upgraded to “Hold” at Zacks Investment Research https://t.co/cBFSuihutg
TickerReport-profile-image
Ticker Report @TickerReport - 12 hours ago
Dova Pharmaceuticals $DOVA Upgraded at Zacks Investment Research https://t.co/8i2yeHRlOU
humour_humourrr-profile-image
humour @humour_humourrr - 12 hours ago
After recent $dova $rarx $achn acquisitions the FIRST thing I do in the morning now is taking my Android device and… https://t.co/bwWUQAdep6
stockmktgenius-profile-image
Stock Market Genius @stockmktgenius - a day ago
$DOVA Dova Pharmaceuticals, Inc Leading stock #BreakOutWatch Recent close 28.06 Liquidity: $17M https://t.co/2zArvstpLg
newsfilterio-profile-image
newsfilter.io @newsfilterio - a day ago
MERGER ALERT – RARX, DOVA, and ROAN: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale… https://t.co/SsMe4js8Lj
AmericanBanking-profile-image
US Banking News @AmericanBanking - a day ago
Dova Pharmaceuticals $DOVA – Research Analysts’ Recent Ratings Changes https://t.co/RjEDZmOQx6 #stocks
ZolmaxNews-profile-image
Zolmax News @ZolmaxNews - a day ago
Dova Pharmaceuticals $DOVA – Research Analysts’ Recent Ratings Changes https://t.co/WgQXFvigkd
brendan_49-profile-image
brendan @brendan_49 - a day ago
$DOVA was made to be bought either by the competitor they directly threatened or by someone else. Same w/ $ACHN aft… https://t.co/P7OYZ9bvzG
TradeStocksNow1-profile-image
TradeStocks @TradeStocksNow1 - 2 days ago
https://t.co/MeUKX7l78B Get Free stock trading masterclasses!!! $AMCN $ETHD $DOVA